Locoregional and distant recurrences after breast conserving therapy in patients with triple-negative breast cancer: A meta-analysis

Surgical Oncology

Volumn 22, Issue 4, 2013, Pages 247-255

  Wang, Jin ^a   Xie, Xiaoming ^a   Wang, Xi ^a   Tang, Jun ^a   Pan, Qingqing ^b   Zhang, Yefan ^c   Di, Mengyang ^d  

^a SUN YAT SEN UNIVERSITY CANCER CENTER   (China)

^b PEKING UNION MEDICAL COLLEGE HOSPITAL   (China)

^c CANCER HOSPITAL   (China)

^d CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Breast conserving therapy; Distant metastasis; Locoregional recurrence; Mastectomy; Triple negative breast cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

CANCER ADJUVANT THERAPY; CANCER PROGNOSIS; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURGERY; DISTANT METASTASIS; FOLLOW UP; HUMAN; META ANALYSIS; OUTCOME ASSESSMENT; PARTIAL MASTECTOMY; PHENOTYPE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVIEW; TRIPLE NEGATIVE BREAST CANCER;

BREAST CONSERVING THERAPY; DISTANT METASTASIS; LOCOREGIONAL RECURRENCE; MASTECTOMY; TRIPLE-NEGATIVE BREAST CANCER;

FEMALE; HUMANS; MASTECTOMY, SEGMENTAL; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; TRIPLE NEGATIVE BREAST NEOPLASMS;

EID: 84889658332     PISSN: 09607404     EISSN: 18793320     Source Type: Journal    
DOI: 10.1016/j.suronc.2013.10.001     Document Type: Review

References (65)

1. C.M. Perou, T. Sorlie, M.B. Eisen, M. van de Rijn, S.S. Jeffrey, and C.A. Rees Molecular portraits of human breast tumours Nature 406 2000 747 752
2. T. Sorlie Molecular portraits of breast cancer: tumour subtypes as distinct disease entities Eur J Cancer 40 2004 2667 2675
3. T. Sorlie, C.M. Perou, R. Tibshirani, T. Aas, S. Geisler, and H. Johnsen Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci U S A 98 2001 10869 10874
4. J.D. Brenton, L.A. Carey, A.A. Ahmed, and C. Caldas Molecular classification and molecular forecasting of breast cancer: ready for clinical application? J Clin Oncol 23 2005 7350 7360
5. R. Rouzier, C.M. Perou, W.F. Symmans, N. Ibrahim, M. Cristofanilli, and K. Anderson Breast cancer molecular subtypes respond differently to preoperative chemotherapy Clin Cancer Res 11 2005 5678 5685
6. C. Sotiriou, S.Y. Neo, L.M. McShane, E.L. Korn, P.M. Long, and A. Jazaeri Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci U S A 100 2003 10393 10398
7. J.I. Herschkowitz, K. Simin, V.J. Weigman, I. Mikaelian, J. Usary, and Z. Hu Identification of conserved gene expression features between murine mammary carcinoma models and human breast tumors Genome Biol 8 2007 R76
8. L.A. Carey, C.M. Perou, C.A. Livasy, L.G. Dressler, D. Cowan, and K. Conway Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study JAMA 295 2006 2492 2502
9. A. Potti, H.K. Dressman, A. Bild, R.F. Riedel, G. Chan, and R. Sayer Genomic signatures to guide the use of chemotherapeutics Nat Med 12 2006 1294 1300
10. K.M. O'Brien, S.R. Cole, C.K. Tse, C.M. Perou, L.A. Carey, and W.D. Foulkes Intrinsic breast tumor subtypes, race, and long-term survival in the Carolina breast cancer study Clin Cancer Res 16 2010 6100 6110
11. A. Spitale, P. Mazzola, D. Soldini, L. Mazzucchelli, and A. Bordoni Breast cancer classification according to immunohistochemical markers: clinicopathologic features and short-term survival analysis in a population-based study from the South of Switzerland Ann Oncol 20 2009 628 635
12. E.A. Rakha, J.S. Reis-Filho, and I.O. Ellis Basal-like breast cancer: a critical review J Clin Oncol 26 2008 2568 2581
13. B. Weigelt, F.L. Baehner, and J.S. Reis-Filho The contribution of gene expression profiling to breast cancer classification, prognostication and prediction: a retrospective of the last decade J Pathol 220 2010 263 280
14. C. Sotiriou, and L. Pusztai Gene-expression signatures in breast cancer N Engl J Med 360 2009 790 800
15. B. Kreike, M. van Kouwenhove, H. Horlings, B. Weigelt, H. Peterse, and H. Bartelink Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas Breast Cancer Res 9 2007 R65
16. J.S. Reis-Filho, and A.N. Tutt Triple negative tumours: a critical review Histopathology 52 2008 108 118
17. B.B. Bryan, S.J. Schnitt, and L.C. Collins Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer Mod Pathol 19 2006 617 621
18. W.D. Foulkes, I.E. Smith, and J.S. Reis-Filho Triple-negative breast cancer N Engl J Med 363 2010 1938 1948
19. M. Clarke, R. Collins, S. Darby, C. Davies, P. Elphinstone, and E. Evans Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials Lancet 366 2005 2087 2106
20. S. Aebi, T. Davidson, G. Gruber, and M. Castiglione Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 21 Suppl. 5 2010 v9 14
21. F. Cardoso, E. Senkus-Konefka, L. Fallowfield, A. Costa, and M. Castiglione Locally recurrent or metastatic breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up Ann Oncol 21 Suppl. 5 2010 v15 v19
22. B. Fisher, S. Anderson, J. Bryant, R.G. Margolese, M. Deutsch, and E.R. Fisher Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer N Engl J Med 347 2002 1233 1241
23. U. Veronesi, N. Cascinelli, L. Mariani, M. Greco, R. Saccozzi, and A. Luini Twenty-year follow-up of a randomized study comparing breast-conserving surgery with radical mastectomy for early breast cancer N Engl J Med 347 2002 1227 1232
24. S.H. Yang, K.H. Yang, Y.P. Li, Y.C. Zhang, X.D. He, and A.L. Song Breast conservation therapy for stage I or stage II breast cancer: a meta-analysis of randomized controlled trials Ann Oncol 19 2008 1039 1044
25. W. Eiermann, and K.A. Vallis Locoregional treatments for triple-negative breast cancer Ann Oncol 23 Suppl. 6 2012 vi30 vi34
26. C.C. Parker, F. Ampil, G. Burton, B.D. Li, and Q.D. Chu Is breast conservation therapy a viable option for patients with triple-receptor negative breast cancer? Surgery 148 2010 386 391
27. A.Y. Ho, G. Gupta, T.A. King, C.A. Perez, S.M. Patil, and K.H. Rogers Favorable prognosis in patients with T1a/T1bN0 triple-negative breast cancers treated with multimodality therapy Cancer 118 2012 4944 4952
28. K.D. Voduc, M.C. Cheang, S. Tyldesley, K. Gelmon, T.O. Nielsen, and H. Kennecke Breast cancer subtypes and the risk of local and regional relapse J Clin Oncol 28 2010 1684 1691
29. F.C. Adkins, A.M. Gonzalez-Angulo, X. Lei, L.F. Hernandez-Aya, E.A. Mittendorf, and J.K. Litton Triple-negative breast cancer is not a contraindication for breast conservation Ann Surg Oncol 18 2011 3164 3173
30. C.U. Ihemelandu, T.J. Naab, H.M. Mezghebe, K.H. Makambi, S.M. Siram, and L.D. Leffall Jr. Treatment and survival outcome for molecular breast cancer subtypes in black women Ann Surg 247 2008 463 469
31. P.L. Nguyen, A.G. Taghian, M.S. Katz, A. Niemierko, R.F. Abi Raad, and W.L. Boon Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy J Clin Oncol 26 2008 2373 2378
32. E.K. Millar, P.H. Graham, S.A. O'Toole, C.M. McNeil, L. Browne, and A.L. Morey Prediction of local recurrence, distant metastases, and death after breast-conserving therapy in early-stage invasive breast cancer using a five-biomarker panel J Clin Oncol 27 2009 4701 4708
33. G.M. Freedman, P.R. Anderson, T. Li, and N. Nicolaou Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation Cancer 115 2009 946 951
34. B.G. Haffty, Q. Yang, M. Reiss, T. Kearney, S.A. Higgins, and J. Weidhaas Locoregional relapse and distant metastasis in conservatively managed triple negative early-stage breast cancer J Clin Oncol 24 2006 5652 5657
35. R.D. Riley, K.R. Abrams, A.J. Sutton, P.C. Lambert, D.R. Jones, and D. Heney Reporting of prognostic markers: current problems and development of guidelines for evidence-based practice in the future Br J Cancer 88 2003 1191 1198
36. J.P.T.S. Higgins, J.J. Deeks, and D.G. Altman Measuring inconsistency in meta-analyses BMJ 327 2003 557 560
37. J.P. Higgins, and S.G. Thompson Quantifying heterogeneity in a meta-analysis Stat Med 21 2002 1539 1558
38. P. Boyle, M. Boniol, A. Koechlin, C. Robertson, F. Valentini, and K. Coppens Diabetes and breast cancer risk: a meta-analysis Br J Cancer 107 2012 1608 1617
39. B.S. Abdulkarim, J. Cuartero, J. Hanson, J. Deschenes, D. Lesniak, and S. Sabri Increased risk of locoregional recurrence for women with T1-2N0 triple-negative breast cancer treated with modified radical mastectomy without adjuvant radiation therapy compared with breast-conserving therapy J Clin Oncol 29 2011 2852 2858
40. A.E. Dragun, J. Pan, S.N. Rai, B. Kruse, and D. Jain Locoregional recurrence in patients with triple-negative breast cancer: preliminary results of a single institution study Am J Clin Oncol 34 2011 231 237
41. Z. Gabos, J. Thoms, S. Ghosh, J. Hanson, J. Deschenes, and S. Sabri The association between biological subtype and locoregional recurrence in newly diagnosed breast cancer Breast Cancer Res Treat 124 2010 187 194
42. K. Han, S. Nofech-Mozes, S. Narod, W. Hanna, D. Vesprini, and R. Saskin Expression of HER2neu in ductal carcinoma in situ is associated with local recurrence Clin Oncol (R Coll Radiol) 24 2012 183 189
43. I.M. Pashtan, A. Recht, M. Ancukiewicz, E. Brachtel, R.F. Abi-Raad, and H.A. D'Alessandro External beam accelerated partial-breast irradiation using 32 gy in 8 twice-daily fractions: 5-year results of a prospective study Int J Radiat Oncol Biol Phys 84 2012 e271 e277
44. J.A. Hattangadi-Gluth, J.Y. Wo, P.L. Nguyen, R.F. Abi Raad, M. Sreedhara, and A. Niemierko Basal subtype of invasive breast cancer is associated with a higher risk of true recurrence after conventional breast-conserving therapy Int J Radiat Oncol Biol Phys 82 2012 1185 1191
45. N.D. Arvold, A.G. Taghian, A. Niemierko, R.F. Abi Raad, M. Sreedhara, and P.L. Nguyen Age, breast cancer subtype approximation, and local recurrence after breast-conserving therapy J Clin Oncol 29 2011 3885 3891
46. J.M. Noh, D.H. Choi, S.J. Huh, W. Park, J.H. Yang, and S.J. Nam Patterns of recurrence after breast-conserving treatment for early stage breast cancer by molecular subtype J Breast Cancer 14 2011 46 51
47. V. Barbieri, P. Sanpaolo, and D. Genovesi Prognostic impact of triple negative phenotype in conservatively treated breast cancer Breast J 17 2011 377 382
48. S.S. Zaky, M. Lund, K.A. May, K.D. Godette, J.J. Beitler, and L.R. Holmes The negative effect of triple-negative breast cancer on outcome after breast-conserving therapy Ann Surg Oncol 18 2011 2858 2865
49. F.Y. Wong, F.K. Chin, K.A. Lee, Y.L. Soong, and E.T. Chua Hormone receptors and HER-2 status as surrogates for breast cancer molecular subtypes prognosticate for disease control in node negative Asian patients treated with breast conservation therapy Ann Acad Med Singapore 40 2011 7
50. E.T. Siponen, L. Vaalavirta, H. Joensuu, J. Vironen, P. Heikkila, and M.H. Leidenius Ipsilateral breast recurrence after breast conserving surgery in patients with small (
51. L.J. Solin, W.T. Hwang, and N. Vapiwala Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma Clin Breast Cancer 9 2009 96 100
52. A. Stang Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses Eur J Epidemiol 25 2010 603 605
53. R. Arriagada, M.G. Le, F. Rochard, and G. Contesso Conservative treatment versus mastectomy in early breast cancer: patterns of failure with 15 years of follow-up data. Institut Gustave-Roussy Breast Cancer Group J Clin Oncol 14 1996 1558 1564
54. M. Blichert-Toft, C. Rose, J.A. Andersen, M. Overgaard, C.K. Axelsson, and K.W. Andersen Danish randomized trial comparing breast conservation therapy with mastectomy: six years of life-table analysis. Danish Breast Cancer Cooperative Group J Natl Cancer Inst Monogr 1992 19 25
55. B. Fisher, C. Redmond, R. Poisson, R. Margolese, N. Wolmark, and L. Wickerham Eight-year results of a randomized clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer N Engl J Med 320 1989 822 828
56. M.M. Poggi, D.N. Danforth, L.C. Sciuto, S.L. Smith, S.M. Steinberg, and D.J. Liewehr Eighteen-year results in the treatment of early breast carcinoma with mastectomy versus breast conservation therapy: the National Cancer Institute randomized trial Cancer 98 2003 697 702
57. J.A. van Dongen, H. Bartelink, I.S. Fentiman, T. Lerut, F. Mignolet, and G. Olthuis Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer Eur J Cancer 28A 1992 801 805
58. J.A. van Dongen, A.C. Voogd, I.S. Fentiman, C. Legrand, R.J. Sylvester, and D. Tong Long-term results of a randomized trial comparing breast-conserving therapy with mastectomy: European organization for research and treatment of cancer 10801 trial J Natl Cancer Inst 92 2000 1143 1150
59. U. Veronesi, A. Banfi, M. Del Vecchio, R. Saccozzi, C. Clemente, and M. Greco Comparison of Halsted mastectomy with quadrantectomy, axillary dissection, and radiotherapy in early breast cancer: long-term results Eur J Cancer Clin Oncol 22 1986 1085 1089
60. M. Kyndi, F.B. Sorensen, H. Knudsen, M. Overgaard, H.M. Nielsen, and J. Overgaard Estrogen receptor, progesterone receptor, HER-2, and response to postmastectomy radiotherapy in high-risk breast cancer: the Danish Breast Cancer Cooperative Group J Clin Oncol 26 2008 1419 1426
61. H. Yagata, Y. Kajiura, and H. Yamauchi Current strategy for triple-negative breast cancer: appropriate combination of surgery, radiation, and chemotherapy Breast Cancer 18 2011 165 173
62. U. Veronesi, E. Marubini, L. Mariani, V. Galimberti, A. Luini, and P. Veronesi Radiotherapy after breast-conserving surgery in small breast carcinoma: long-term results of a randomized trial Ann Oncol 12 2001 997 1003
63. R.W. Carlson, D.C. Allred, B.O. Anderson, H.J. Burstein, W.B. Carter, and S.B. Edge Breast cancer. Clinical practice guidelines in oncology J Natl Compr Canc Netw 7 2009 122 192
64. M.D. Valentin, S.D. da Silva, M. Privat, M. Alaoui-Jamali, and Y.J. Bignon Molecular insights on basal-like breast cancer Breast Cancer Res Treat 134 2012 21 30
65. N.T. Ueno, and D. Zhang Targeting EGFR in triple negative breast cancer J Cancer 2 2011 324 328